WJNS  Vol.3 No.3 , August 2013
Clinico-radiological dissociation in multiple sclerosis: Future prospects
ABSTRACT

Magnetic resonance imaging (MRI) has significantly contributed to our capabilities of diagnosis multiple sclerosis (MS) since it is able to detect demyelinating lesions in almost 100% of patients. However, there are modest correlations between irreversible disability and white matter lesion load, as measured by T2-weighted MRI scans, which represents the clinicoradiological paradox of MS. We report the case of a patient with MS and few neurological manifestations despite extensive T2 visible morphologic abnormalities. The use of non-conventional MRI techniques, which are more specific in the analysis of the pathological substrate of demyelinating lesions and normal appearing brain matter (both white and gray matter), might assist us to overcome this limitation of conventional MRI.


Cite this paper
Zapata-Arriaza, E. and Díaz-Sánchez, M. (2013) Clinico-radiological dissociation in multiple sclerosis: Future prospects. World Journal of Neuroscience, 3, 147-153. doi: 10.4236/wjns.2013.33019.
References
[1]   Mostert, J.P., Koch, M.W., Steen, C., Heersema, D.J., De Groot, J.C. and De Keyser, J. (2010) T2 lesions and rate of progression of disability in multiple sclerosis. European Journal of Neurology, 17, 1471-1475. doi:10.1111/j.1468-1331.2010.03093.x

[2]   Pelletier, J., Audoin, B., Reuter, F. and Ranjeva, J. (2009) Plasticity in MS: From functional imaging to rehabilitation. The International MS Journal, 16, 26-31.

[3]   Zivadinov, R. (2009) Advanced magnetic resonance imaging metrics: Implications for multiple sclerosis clinical trials. Methods and Findings in Experimental and Clinical Pharmacology, 31, 29-40. doi:10.1358/mf.2009.31.1.1346612

[4]   Strasser-Fuchs, S., Enzinger, C., Ropele, S., Wallner, M. and Fazekas, F. (2008) Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox? Multiple Sclerosis Journal, 14, 205-211. doi:10.1177/1352458507082354

[5]   Barkhof, F. (2002) The clinico-radiological paradox in multiple sclerosis revisited. Current Opinion in Neurology, 15, 239-245. doi:10.1097/00019052-200206000-00003

[6]   Polman, C.H., Reingold, S.C., Banwell, B., Clanet, M., Cohen, J.A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F.D., Montalban, X., O’Connor, P., Sandberg-Wollheim, M., Thompson, A.J., Waubant, E., Weinshenker, B. and Wolinsky, J.S. (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology, 69, 292-302. doi:10.1002/ana.22366

[7]   Paty, D.W., Oger, J.J., Kastrukoff, L.F., Hashimoto, S.A., Hooge, J.P., Eisen, A.A., et al. (1988) MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology, 38, 180-185. doi:10.1212/WNL.38.2.180

[8]   McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B.Y. and Wolinsky, J.S. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50, 121-127. doi:10.1002/ana.1032

[9]   Van Walderveen, M.A.A., Barkhof, F., Hommes, O.R., Polman, C.H., Tobi, H., Frequin, S.T.F.M., et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology, 45, 1684-1690. doi:10.1212/WNL.45.9.1684

[10]   Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology (Cleveland), 33, 1444-1452. doi:10.1212/WNL.33.11.1444

[11]   Pike, G.B., De Stefano, N., Narayanan, S., et al. (1999) Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. American Journal of Neuroradiology, 20, 829-837.

[12]   Filippi, M., McGowan, J.C. and Tortorella, C. (2007) Measures of magnetization transfer in multiple sclerosis. In: Cohen, J.A. and Rudick, R.A., Eds. Multiple Sclerosis Therapeutics, 3rd Edition, Informa Healthcare, London, 143-144, 171.

[13]   Carlos Santos, A., Narayanan, S., De Stefano, N., et al. (2000) Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. Journal of Neurology, 249, 662-668. doi:10.1007/s00415-002-0686-4

[14]   Fox, R.J. (2008) Picturing multiple sclerosis: Conventional and diffusion tensor imaging. Seminars in Neurology, 28, 453-466. doi:10.1055/s-0028-1083689

[15]   Vrenken, H., Pouwels, P.J.W., Geurts, J.J.G., et al. (2006) Altered diffusion in multiple sclerosis normal appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration. Journal of Magnetic Resonance Imaging, 23, 628-636. doi:10.1002/jmri.20564

[16]   Audoin, B., Maxime, G., Reuter, F., et al. (2007) Structure of WM bundles constituting the working memory system in early multiple sclerosis: A quantitative DTI tractography study. NeuroImage, 36, 1324-1330. doi:10.1016/j.neuroimage.2007.04.038

[17]   Fu, L., Matthews, P.M., De Stefano, N., et al. (1998) Imaging of axonal damage of normal appearing white matter in multiple sclerosis. Brain, 121, 103-113. doi:10.1093/brain/121.1.103

[18]   Mathews, P.M., Francis, G., Antel, J. and Arnold, D.L. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology, 41, 1521-1526. doi:10.1212/WNL.41.8.1251

[19]   Chard, D.T., Griffin, C.M., McLean, M.A., et al. (2002) Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain, 125, 2342-2352. doi:10.1093/brain/awf240

[20]   Rocca, M.A., Colombo, B., Falini, A., Ghezzi, A., Martinelli, V., Scotti, G., et al. (2005) Cortical adaptation in patients with MS: A cross-sectional functional MRI study of disease phenotypes. The Lancet Neurology, 4, 618-626. doi:10.1016/S1474-4422(05)70171-X

[21]   Mainero, C., Pantano, P., Caramia, F. and Pozzilli, C. (2006) Brain reorganization during attention and memory tasks in multiple sclerosis: Insights from functional MRI studies. Journal of the Neurological Sciences, 245, 93-98. doi:10.1016/j.jns.2005.08.024

 
 
Top